John L. Marshall, MD: Zolbetuximab is a drug that you probably don’t know the name of, but you’re going to soon. Though you may have heard of claudin 18.2. Now, that’s been in the literature for a ...

The Administrative Core will provide for overall direction, coordination, and administration of the Case Gl SPORE, including oversight of the SPORE Executive Committee, SPORE Internal Advisory Board, ...

A population-based study drew a possible connection between gastrointestinal (GI) symptoms and the multiple sclerosis (MS) prodrome. Patients with multiple sclerosis (MS) endure higher rates of drug ...

71.4% of MetaXplore™ reports from 4,616 patients identified actionable results 41.9% tested positive for abnormal microbiome markers linked to gastrointestinal health 9.9% tested positive for ...

Gastrointestinal disorders may affect around 40% of people worldwide, according to one recent study. GI disorders can include several conditions, including celiac disease, gastritis, Crohn's disease, ...